Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.
Therapy with oral 5-aminosalicylic acid (5-ASA) for ulcerative colitis has been reported to be effective and safe. We describe a case of biochemically proven mild acute pancreatitis occurring after 9 d of oral 5-ASA therapy for ulcerative colitis. A hypersensitivity mechanism seemed to be involved in the development of pancreatitis probably owing to erratic systemic absorption of the drug. We suggest clinical and biochemical monitoring for early diagnosis of pancreatitis in patients with ulcerative colitis receiving 5-ASA administration. This is the first report of acute pancreatitis developed by oral 5-ASA therapy for the treatment of ulcerative colitis in the literature of Japan.
Adachi
E
E
Department of Gastroenterology and Hepatology, and Endoscopic Medicine, Kyoto University Hospital, Japan.
Okazaki
K
K
Matsushima
Y
Y
Seno
H
H
Uchida
K
K
Nakase
H
H
Kawanami
C
C
Nakamura
T
T
Chiba
T
T
D000208:Acute Disease; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000276:immunology; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000276:immunology; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D019804:Mesalamine / Q000009:adverse effects* / Q000276:immunology; D010195:Pancreatitis / Q000139:chemically induced* / Q000175:diagnosis
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine